Patients with higher risk scores received higher scores of immune functions, including APC costimulation, DCs, CD8+ T cells, checkpoints, cytolytic activity, inflammation promotion, macrophages, CCR, parainflammation, T cell coinhibition and stimulation, T helper cells, Tfhs, Th1/2 cells, regulatory T cells (Tregs), and tumour infiltrating lymphocytes (TILs) (Figure S4). This evidence concerns the gene CD8A and neoplasm.